Apollo Cancer Centres & Accuray Launch India's First Robotic Stereotactic Radiotherapy Program

Apollo Cancer Centres (ACC), in collaboration with Accuray, a global provider of radiation therapy devices, has announced the launch of the India Sub-Continent’s first robotic and stereotactic therapy education centre. 

In a press statement on Tuesday, the cancer centre informed  that this new initiative, the Robotic & Stereotactic Radiosurgery program, will be established at ACC locations in Chennai and Bangalore, providing advanced radiosurgery educational training to radiation oncologists, physicists, radiation therapists, and technologists from across India and the sub-continent.

The program will include comprehensive discussions, demonstrations, and hands-on training focusing on robotic and stereotactic radiosurgery. This initiative represents a significant milestone in India’s medical education landscape, making world-class training accessible locally. Participants will engage in in-depth discussions and practical demonstrations to ensure a robust learning experience.

Dinesh Madhavan, President of Group Oncology, and International, Apollo Hospital Enterprises, stated, “In the field of cancer care, ground-breaking technologies pave the way for highly personalised and effective treatment. The inception of the Robotic Stereotactic Radiotherapy Program by Apollo Cancer Centres and Accuray will advance training facilities for the ASEAN region. It will help equip oncologists, physicists, and therapists with the critical knowledge and skills needed to leverage the latest in CyberKnife technology.”

Sridhar PS, Lead- Cyberknife – Robotic Radiosurgery, added, “The launch of the training program at Apollo Cancer Centre is an exceptional opportunity to enhance skills and knowledge in Robotic & Stereotactic Radiotherapy. Since pioneering the Cyberknife Robotic Radio Surgery System in India and a rich experience of over 5000 patients, we will now share valuable knowledge in the training program. It will enable oncologists in the development of Cancer care through Cyberknife training.”

Suzanne Winter, President and CEO of Accuray, commented, “Accuray celebrates the expansion of the CyberKnife S7™ System to Apollo centres in Chennai and Bangalore, showcasing our enduring collaboration with Apollo Hospitals to enhance cancer care in India. With its unparalleled precision, the CyberKnife S7 System redefines treatment standards, empowering clinicians to optimise outcomes. Additionally, it enables the delivery of high doses of radiation, typically in 1 to 5 sessions for fast and effective treatments, marking a significant advancement in cancer therapy.”

The CyberKnife System is a non-invasive, robotic radiation therapy device designed to treat tumours with high precision and minimal damage to surrounding healthy tissue. It uses advanced imaging and computerised robotics to deliver highly focused beams of radiation, allowing for the treatment of complex and hard-to-reach tumours, the statement from the healthcare service provider informed.